Business Context and Reporting Period
This Form 8-K filing by Pavmed Inc. (PAVM) reports on the 2024 Annual Meeting of Stockholders held on June 20, 2024. Approximately 58.5% of outstanding shares entitled to vote were present in person or by proxy.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Stockholders approved two primary matters at the annual meeting:
- Director Elections: Stockholders elected James L. Cox, M.D., and Debra J. White as Class B directors. Their terms will expire at the third succeeding annual meeting.
- James L. Cox, M.D.: 2,177,207 votes For; 128,338 Authority Withheld; 3,209,395 Broker Non-Votes.
- Debra J. White: 2,234,311 votes For; 71,234 Authority Withheld; 3,209,395 Broker Non-Votes.
- Auditor Ratification: Stockholders ratified the appointment of Marcum LLP as the independent registered certified public accounting firm for the year ending December 31, 2024.
- 5,378,887 votes For; 92,448 votes Against; 43,605 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the composition of the Board of Directors following the re-election of Class B directors.
- Confirm the engagement of Marcum LLP as the independent auditor for the fiscal year ending December 31, 2024.
- Review the company's most recent 10-K or 10-Q filings for financial performance data, as this 8-K contains no financial metrics.